Enhanced Medical Nutrition Raises Series A Funding to Revolutionize Nutrition for Surgery

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Enhanced Medical Nutrition, Inc. (EMN), a food-as-medicine company that commercializes novel, evidence-based medical nutrition products to improve outcomes in surgery, recently announced USD $5 million over-subscribed Series A financing round. The funds will be allocated to scale the company's expansion of ENROUTE®, an innovative nutrition program designed for the dietary management of surgery.

Enhanced Medical Nutrition is an alumnus of our BDSP™, CAAP®, and EAHN™ programs.

Arsheen Kaur
Previous

Esphera SynBio Announces New Project to Advance Next Generation mRNA Vaccine Development
Next

Fluid Biomed Closes $27 Million USD Series A to Fund Expanded Human Clinical Studies